FDA Inspection 1309944 — Aspen Notre Dame de Bondeville

Aspen Notre Dame de Bondeville — FEI 3002808079

The FDA completed an inspection of Aspen Notre Dame de Bondeville on November 7, 2025 in Notre-Dame-De-Bondeville. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 7, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Notre-Dame-De-Bondeville (France)

Additional Details

Mutual Recognition Agreement (MRA)